CRISPR technology allows for precise DNA modifications, holding promise for treating genetic disorders and revolutionizing ...

In a potential advance for melanoma patients, researchers at ChristianaCare's Gene Editing Institute have used CRISPR gene ...

Scientists at NC State University have discovered how modifying lignin in trees using CRISPR can make them better suited for ...

Trees are the most abundant natural resource living on Earth's land masses, and North Carolina State University scientists ...

We recently compiled a list of the 10 Most Promising Biotech Stocks According to Hedge Funds. In this article, we are going ...

While the Nobel-winning genome-editing technology CRISPR holds great promise, Duke’s Center for Advanced Genomic Technologies ...

The latest trading day saw CRISPR Therapeutics AG (CRSP) settling at $48.05, representing a +0.47% change from its previous close.

New gene therapies developed using CRISPR gene editing offer the promise of treating or even curing debilitating diseases.

A study reveals that CRISPR gene editing can disable a mutation in melanoma cells that leads to treatment resistance. By targeting the NRAS gene mutation, researchers restored the cells' sensitivity ...

In a potential advance for melanoma patients, researchers at ChristianaCare’s Gene Editing Institute have used CRISPR gene editing tools to disable a gene mutation often seen in aggressive forms of ...

Let's examine what this company is planning for the future, and figure out whether that makes its stock worth buying or not.

On The Readout LOUD, John Maraganore discusses his new startup, and STAT's Megan Molteni tells the latest about "CRISPR baby" ...